UMA
RIGL icon

USA Mutuals Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

USA Mutuals Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-78
Closed -$2K – 226
2016
Q1 		$2K Hold
78
– – ﹤0.01% 159
2015
Q4 		$2K Buy
+78
New +$2.37K ﹤0.01% 173

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

USA Mutuals Advisors's RIGL Position: Q2 2016 in Review

USA Mutuals Advisors sold out of Rigel Pharmaceuticals (RIGL) in Q2 2016, closing a stake of 78 shares — an estimated $2K sold.

USA Mutuals Advisors first reported a position in RIGL in Q4 2015 and held it in 2 quarters. The position peaked at $2K in Q1 2016. 120 funds tracked by Wall St. Rank hold RIGL as of Q2 2016.

  • USA Mutuals Advisors reported no remaining Rigel Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • USA Mutuals Advisors sold 78 Rigel Pharmaceuticals shares in Q2 2016, an estimated $2K.
  • USA Mutuals Advisors first reported a position in Rigel Pharmaceuticals in Q4 2015 and held it in 2 quarters.
  • USA Mutuals Advisors's Rigel Pharmaceuticals position peaked at $2K in Q1 2016.
  • 120 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2016.

Based on USA Mutuals Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.